SCHEMBL5199224

SCHEMBL5199224

CC(=O)Nc1ccc(-c2cccc(-c3nc(C(C)C)[nH]c3-c3cccc(C)n3)c2)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TGFBR1 P36897 10/20 0.50
MAPK14 Q16539 4/20 0.46
IDO1 P14902 1/20 0.41
MEN1 O00255 4/20 0.41
MAPT P10636 4/20 0.41
KMT2A Q03164 4/20 0.41
ALDH1A1 P00352 4/20 0.41
HPGD P15428 4/20 0.41
KDM4E B2RXH2 4/20 0.41
RXFP1 Q9HBX9 2/20 0.41
NPSR1 Q6W5P4 1/20 0.41
CYP2C19 P33261 1/20 0.41
NPC1 O15118 2/20 0.41
RAB9A P51151 2/20 0.41
NFKB1 P19838 1/20 0.41
STAT1 P42224 1/20 0.41
NFKB2 Q00653 1/20 0.41
RELA Q04206 1/20 0.41
ALOX5 P09917 1/20 0.41
ADORA2A P29274 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5200616 0.89 TGFBR1 (0.47) TGFBR1MAPK14KDM4E
SCHEMBL5199177 0.87 TGFBR1 (0.54) TGFBR1MAPK14MAPTKDM4ESMN1; SMN2
SCHEMBL5199601 0.86 TGFBR1 (0.45) TGFBR1MAPK14KDM4E
SCHEMBL5199931 0.84 TGFBR1 (0.48) TGFBR1MAPK14KDM4E
SCHEMBL5199866 0.84 TGFBR1 (0.48) TGFBR1MAPK14KDM4E
SCHEMBL5197656 0.83 TGFBR1 (0.52) TGFBR1MAPK14MEN1KMT2ANPC1
SCHEMBL5200108 0.82 TGFBR1 (0.45) TGFBR1MAPK14ALDH1A1HPGDKDM4E
SCHEMBL5200577 0.82 TGFBR1 (0.53) TGFBR1ALDH1A1
SCHEMBL5201273 0.82 TGFBR1 (0.47) TGFBR1MAPK14KDM4ECYP2C19
SCHEMBL5199441 0.82 TGFBR1 (0.47) TGFBR1MAPK14KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070275968-A1 Substituted Biphenyl Derivative SANKYO COMPANY, LIMITED (JP) 2007-11-29 US disclosed
EP-1798229-A1 SUBSTITUTED BIPHENYL DERIVATIVE Sankyo Company, Limited (JP) 2007-06-20 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070275968-A1 Substituted Biphenyl Derivative COL2A1, COL1A1, FGFR3 TGFBR1 40/4885MAPK14 2998/4885IDO1 418/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.